Vaccination against Lyme Disease with recombinant Borrelia burgdorferi outer-surface protein A (rOspA) in horses

By Chang Y.-F.   Novosol V.   McDonough S.P.   Chang C.-F.   Jacobson R.H.   Divers T.   Quimby F.W.   Shin S.   Lein D.H.  

Vaccine, Vol. 18, Iss. 5, 1999-10 ,pp. : 540-548

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of recombinant Bacille Calmette-Guerin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine

By Edelman R.   Palmer K.   Russ K.G.   Secrest H.P.   Anna L. Becker J.   Bodison S.A.   Perry J.G.   Sills A.R.   Barbour A.G.   Luke C.J.   Hanson M.S.   Stover C.K.   Burlein J.E.   Bansal G.P.   Connor E.M.   Koenig S.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 904-914

Elsevier

Access to resources Recommend Favorite

The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi

By Golde W.T.   Burkot T.R.   Piesman J.   Dolan M.C.   Capiau C.   Hauser P.   Dequesne G.   Lobet Y.  

Vaccine, Vol. 13, Iss. 5, 1995-01 ,pp. : 435-441

Elsevier

Access to resources Recommend Favorite

Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge

By Pal S.   Luke C.J.   Barbour A.G.   Peterson E.M.   de la Maza L.M.  

Vaccine, Vol. 21, Iss. 13, 2003-03 ,pp. : 1455-1465

Elsevier

Access to resources Recommend Favorite

Human immune response to a Pseudomonas aeruginosa outer membrane protein vaccine

By Jang I.-J.   Kim I.-S.   Park W.J.   Yoo K.-S.   Yim D.-S.   Kim H.-K.   Shin S.-G.   Chang W.H.   Lee N.-G.   Jung S.B.   Ahn D.H.   Cho Y.J.   Ahn B.Y.   Lee Y.   Kim Y.G.   Nam S.W.   Kim H.-S.  

Vaccine, Vol. 17, Iss. 2, 1999-01 ,pp. : 158-168

Elsevier

Access to resources Recommend Favorite